Zobrazeno 1 - 5
of 5
pro vyhledávání: '"David Shyr"'
Autor:
Erik S. Blomain, MD, PhD, Alice Jiang, BA, Sarah S. Donaldson, MD, Rajni Agarwal, MD, Alice Bertaina, MD, PhD, David Shyr, MD, Michael L. Eisenberg, MD, Richard T. Hoppe, MD, Susan M. Hiniker, MD, Justin Oh, MD
Publikováno v:
Advances in Radiation Oncology, Vol 8, Iss 1, Pp 101071- (2023)
ABSTRACT: Purpose: Children with leukemia who receive fractionated total body irradiation (fTBI) with 12 to 13.2 Gy as part of conditioning for hematopoietic stem cell transplant are frequently treated with an additional 4 Gy testicular boost to redu
Externí odkaz:
https://doaj.org/article/0ef718d082bc4b0d8260bd421c20d5ba
Publikováno v:
Clinical Hematology International, Vol 3, Iss 1 (2020)
The use of machine learning (ML) and deep learning (DL) methods in hematology includes diagnostic, prognostic, and therapeutic applications. This increase is due to the improved access to ML and DL tools and the expansion of medical data. The utiliza
Externí odkaz:
https://doaj.org/article/254387d56ac5435d905b651b02d4464f
Autor:
Cesar Marquez, Caressa Hui, Eric Simiele, Erik Blomain, Justin Oh, Alice Bertaina, Orly Klein, David Shyr, Alice Jiang, Richard T. Hoppe, Nataliya Kovalchuk, Susan M. Hiniker
Publikováno v:
Pediatric bloodcancerREFERENCES. 69(6)
Total body irradiation (TBI) is an important component of many conditioning regimens for hematopoietic stem cell transplantation (HSCT), most commonly used in pediatric and adolescent/young adult (AYA) patients. We aimed to evaluate outcomes and toxi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9cab909cf36f3d1281d9ea33ca299687
https://pubmed.ncbi.nlm.nih.gov/35373904
https://pubmed.ncbi.nlm.nih.gov/35373904
Autor:
Benjamin Oshrine, Gregory A. Hale, Aleksandra Petrovic, Lauren K. Adams, David Shyr, Ernest K. Amankwah, Anh Thy H. Nguyen
Publikováno v:
Pediatric Transplantation. 24
BACKGROUND The optimal conditioning regimen for alloHCT in children with myeloid malignancies remains undefined. PROCEDURE We performed a retrospective review of children undergoing alloHCT for AML and MDS over a 10-year period (2008-2018) at our ins
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2744e3a2537613a060fa347b5f808a77
https://doi.org/10.1111/petr.13672
https://doi.org/10.1111/petr.13672
Autor:
Alexandra M, Miggelbrink, Brent R, Logan, Rebecca H, Buckley, Roberta E, Parrott, Christopher C, Dvorak, Neena, Kapoor, Hisham, Abdel-Azim, Susan E, Prockop, David, Shyr, Hélène, Decaluwe, Imelda C, Hanson, Alfred, Gillio, Blachy J, Dávila Saldaña, Hermann, Eibel, Gregory, Hopkins, Jolan E, Walter, Jennifer S, Whangbo, Donald B, Kohn, Jennifer M, Puck, Morton J, Cowan, Linda M, Griffith, Elie, Haddad, Richard J, O'Reilly, Luigi D, Notarangelo, Sung-Yun, Pai
Publikováno v:
Blood. 131(26)
Allogeneic hematopoietic stem cell transplant (HSCT) typically results in donor T-cell engraftment and function in patients with severe combined immunodeficiency (SCID), but humoral immunity, particularly when using donors other than matched siblings
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::90715c00cfa30227378259e0e15b02ae
https://pubmed.ncbi.nlm.nih.gov/29728406
https://pubmed.ncbi.nlm.nih.gov/29728406